MPL K39N, prevalent in 7% of African Americans, leads to mild thrombocytosis in heterozygous individuals and more pronounced effects in homozygous cases, likely due to its low cellular expression suggesting a loss-of-function (LOF) mutation. Here, MPL is linked to thrombocytosis disease.